Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression
File version
Version of Record (VoR)
Author(s)
Trappetti, Claudia
Van Den Bergh, Annelies
Martin, Gael
Calcutt, Ainslie
Ozberk, Victoria
Guillon, Patrice
Pandey, Manisha
von Itzstein, Mark
Swords, W Edward
Paton, James C
Jennings, Michael P
Atack, John M
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
Streptococcus pneumoniae is the most common cause of bacterial illness worldwide. Current vaccines based on the polysaccharide capsule are only effective against a limited number of the >100 capsular serotypes. A universal vaccine based on conserved protein antigens requires a thorough understanding of gene expression in S. pneumoniae. All S. pneumoniae strains encode the SpnIII Restriction-Modification system. This system contains a phase-variable methyltransferase that switches specificity, and controls expression of multiple genes-a phasevarion. We examined the role of this phasevarion during pneumococcal pathobiology, and determined if phase variation resulted in differences in expression of currently investigated conserved protein antigens. Using locked strains that express a single methyltransferase specificity, we found differences in clinically relevant traits, including survival in blood, and adherence to and invasion of human cells. We also observed differences in expression of numerous proteinaceous vaccine candidates, which complicates selection of antigens for inclusion in a universal protein-based pneumococcal vaccine. This study will inform vaccine design against S. pneumoniae by ensuring only stably expressed candidates are included in a rationally designed vaccine. IMPORTANCE S. pneumoniae is the world's foremost bacterial pathogen. S. pneumoniae encodes a phasevarion (phase-variable regulon), that results in differential expression of multiple genes. Previous work demonstrated that the pneumococcal SpnIII phasevarion switches between six different expression states, generating six unique phenotypic variants in a pneumococcal population. Here, we show that this phasevarion generates multiple phenotypic differences relevant to pathobiology. Importantly, expression of conserved protein antigens varies with phasevarion switching. As capsule expression, a major pneumococcal virulence factor, is also controlled by the phasevarion, our work will inform the selection of the best candidates to include in a rationally designed, universal pneumococcal vaccine.
Journal Title
Microbiology Spectrum
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2022 Phillips et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Item Access Status
Note
This publication has been entered in Griffith Research Online as an advanced online version.
Access the data
Related item(s)
Subject
Microbiology
Streptococcus pneumoniae
epigenetic regulation
phase variation
phasevarion
pneumococcus
Persistent link to this record
Citation
Phillips, ZN; Trappetti, C; Van Den Bergh, A; Martin, G; Calcutt, A; Ozberk, V; Guillon, P; Pandey, M; von Itzstein, M; Swords, WE; Paton, JC; Jennings, MP; Atack, JM, Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression, Microbiology Spectrum, 2022, pp. e0091622